Barbora Gaálová Radochova

Dr. Barbora Gaálová Radochova

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2021 in Microorganisms
Verified
Journal Article
Open access
PDF file
Nitin Chandra Teja DadiNitin Chandra Teja Dadi
Nitin Chandra Teja Dadi
BRBarbora Gaálová Radochova
Barbora Gaálová Radochova
Jarmila Czucz VargaJarmila Czucz Varga
Jarmila Czucz Varga
Helena BujdákováHelena Bujdáková
Helena Bujdáková
Healthcare-associated infections (HAIs) are caused by nosocomial pathogens. HAIs have an immense impact not only on developing countries but also on highly developed parts of world. They are predominantly device-associated infections that are caused by the planktonic form of microorganisms as well as those organized in biofilms. This review elucidates the impact of HAIs, focusing on device-associated infections such as central line-associated bloodstream infection including catheter infection, catheter-associated urinary tract infection, ventilator-associated pneumonia, and surgical site infections. The most relevant microorganisms are mentioned in terms of their frequency of infection on medical devices. Standard care bundles, conventional therapy, and novel approaches against device-associated infections are briefly mentioned as well. This review concisely summarizes relevant and up-to-date information on HAIs and HAI-associated microorganisms and also provides a description of several useful approaches for tackling HAIs.

23 February 2023 in Antibiotics
Verified
Journal Article
Open access
PDF file
BRBarbora Gaálová Radochova
Barbora Gaálová Radochova
SKSamuel Kendra
Samuel Kendra
LJLuisa Jordao
Luisa Jordao
LKLaura Kursawe
Laura Kursawe
JKJudith Kikhney
Judith Kikhney
Helena BujdákováHelena Bujdáková
Helena Bujdáková
The natural bioactive molecule farnesol (FAR) is widely studied mainly for its antibiofilm and antimicrobial properties. In addition, it increases the effectiveness of some antimicrobial substances, which makes it interesting for the development of combined therapy. In the present work, the effect of FAR either alone or in combination with oxacillin (OXA) on mixed biofilms formed by clinically relevant pathogens, Candida albicans and Staphylococcus aureus, was studied. S. aureus isolates used for biofilm formation originated from blood cultures and central venous catheters (CVC) were characterized in terms of antimicrobial resistance. The minimal biofilm inhibitory concentration (MBIC50) for FAR of 48 h mixed biofilms formed by the C. albicans and methicillin-sensitive S. aureus (MSSA) was determined to be 125 μM, and for the mixed biofilms with methicillin-resistant S. aureus (MRSA) was determined to be 250 μM. Treatment of mixed biofilms with OXA (2 mg/mL) showed ≤4% inhibition; however, the combination of OXA (2 mg/mL) and FAR (300 μM) resulted in 80% inhibition of biofilms. In addition, planktonic cells of S. aureus exhibited an increased susceptibility to OXA, cefoxitin and kanamycin in the presence of FAR (150 and 300 μM). Scanning electron microscopy (SEM) micrographs confirmed patchy biofilm and lack of candidal hyphae in the samples treated with FAR and FAR/OXA in comparison to control and mixed biofilms treated only with OXA. Intriguingly, in a pilot experiment using fluorescence in situ hybridization (FISH), considerable differences in activity (as indicated by ribosome content) of staphylococcal cells were detected. While the activity rate of the staphylococci in mixed biofilms treated with FAR was high, no FISH-positive signal for staphylococcal cells was found in the biofilm treated with FAR/OXA.

11 January 2024 in Biology Methods and Protocols
Verified
Journal Article
Open access
PDF file
SKSamuel Kendra
Samuel Kendra
Jarmila Czucz VargaJarmila Czucz Varga
Jarmila Czucz Varga
BRBarbora Gaálová Radochova
Barbora Gaálová Radochova
Helena BujdákováHelena Bujdáková
Helena Bujdáková
Determining the number of viable cells by calculating colony-forming units is time-consuming. The evaluation of mixed biofilms consisting of different species is particularly problematic. Therefore, the aim of this study was to optimize a molecular method—propidium monoazide quantitative polymerase chain reaction (PMA-qPCR) - for accurate and consistent differentiation between living and dead cells. In the practical experimental example, the number of genome copies representing living cells was determined in a mixed biofilm of Candida albicans-Staphylococcus aureus inhibited by photodynamic inactivation. Optimal conditions such as PMA concentration and the duration of light exposure, the optimization of DNA isolation from the mixed biofilm and standardization of PMA-qPCR parameters were tested prior to the main experiment. The genome copy number was calculated based on the known amount of gDNA in the qPCR reaction and the genome size of the respective microorganism. The results showed that PDI in the presence of 1 mM methylene blue decreased the total genome copy number from 1.65x108 to 3.19x107, and from 4.39x107 to 1.91x107 for S. aureus and C. albicans (p < 0.01), respectively. The main disadvantage is overestimation of the number of living cells represented by genome copy numbers. Such cells are unable to reproduce and grow (no vitality), and are continuously dying. On the other hand, PMA-qPCR determines the copy numbers of all microbial species, including a mix of eukaryotic yeasts and prokaryotic bacteria in a biofilm in one step, which is a great advantage.